🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patient therapy is tailored according to the molecular profile of the patie...
Status
Completed
Location
Georgetown University- Lombardi Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01888978
Using alternative neoadjuvant gemcitabine-nab-paclitaxel and nal-IRI with 5...
Status
Unknown
Location
Virginia mason medical Center
Start Date
2018-09-17
Trial ID
NCT03703063
Treatments Being Tested
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
This is an open-label, multicenter, multi-dose escalation and dose expansio...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2021-03-19
Trial ID
NCT04731467
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-10-16
Trial ID
NCT06625320
This is an open-label, phase 2 non-comparative study to assess the safety, ...
Status
Completed
Location
University of South Alabama
Start Date
2015-10-19
Trial ID
NCT02551991
Treatments Being Tested
The purpose of this study is to evaluate the safety profile, tolerability, ...
Status
Completed
Location
Local Institution - 0003
Start Date
2017-08-08
Trial ID
NCT03184870
Treatments Being Tested
This phase II trial compares two treatment combinations: gemcitabine hydroc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-08-26
Trial ID
NCT04233866
To determine recommended phase 2 dose and to evaluate the safety of vactose...
Status
Unknown
Location
Samsung Medical Center
Start Date
2021-04-19
Trial ID
NCT04258072
Treatments Being Tested
In Europe, pancreatic cancer (PC) is the 7th most common cancer and the 5th...
Status
Completed
Location
Clinique privée de l'Europe
Start Date
2018-11-16
Trial ID
NCT03693677
Treatments Being Tested